NanoPorT Workshop
Nanoparticles and Proton Therapy for Cancer Treatment
Workshop Date: January 26, 2023, 9 a.m. - 5 p.m.
Venu: Online
Organizer: SYNGOPRO Consortium
Aim and Scope
The NanoPorT Workshop brings together scientific professionals from the fields of nanoparticles in biomedical applications, proton therapy and cancer treatment to highlight recent outcomes of the field and the SYNGOPRO project. It sets the stage for keynote lectures, networking opportunities and discussions about possibilities, challenges and future perspectives of the field among a targeted audience.
The event is planned as an online event, with only virtual components. The SYNGOPRO consortium is committed to keeping attendees safe from COVID-19.
Invited Speaker
Prof. Dr. George Iliakis, Experimental Radiation Biology, University Hospital Essen
Prof. Dr. Inge Herrmann, Nanoparticle Systems Engineering Laboratory, ETH-Zürich
Prof. Dr. Oliver Jäkel, Medical Physics in Radiotherapy, German Cancer Research Center (DKFZ), Heidelberg
General Information
Dear colleagues and friends,
It is a pleasure to invite you to the SYNGOPRO Workshop on Nanoparticles and Proton Therapy for Cancer Treatment (NanoPorT)!
After a successful 3-year period of the SYNGOPRO consortium, we look forward to discuss recent advancements at the interface of nanoparticles in biomedical research, proton therapy and cancer treatment. Registration is now open. We are looking forward to outstanding keynote lectures, lively discussions, poster presentations, and a get together of an interdisciplinary scientific community to exchange ideas, experiences and knowledge.
Due to the uncertainties of the ongoing COVID-19 pandemic, the workshop will be held virtually on January 26, 2023, 9 a.m. - 5 p.m. The workshop language will be English, and we also invite international researchers to attend the workshop and to present their most recent results in a talk or during our poster session.
We look forward to meet you in 2023!
Scientific Organizers
Prof. Dr. Beate Timmermann
Clinic for Particle Therapy
West German Proton Therapy Centre Essen
University Hospital Essen
Prof. Dr. Stephan Barcikowski
Technical Chemistry I
CENIDE
Universiy of Duisburg-Essen
Prof. Dr. Alexander Schramm
West German Cancer Center
Department of Medical Oncology
Molecular Oncology
Dr. Stephan Tippelt
Pediatrics III
Pediatric Oncology and Hematology
University Hospital Essen
Scientific Program
Keynote Speaker I
Prof. Dr. George Iliakis
Head of Experimental Radiation Biology,
University Hospital Essen
Talk title: "Pathways of DNA Double Strand Break Repair and their mechanistic contributions to tumor cell radiosensitization."
Keynote Speaker II
Prof. Dr. Inge Herrmann
Nanoparticle Systems Engineering Laboratory,
ETH-Zürich
Talk title: "Nanoparticle-enhanced photon and proton therapy."
Keynote Speaker III
Prof. Dr. Oliver Jäkel
Medical Physics in Radiotherapy
German Cancer Research Center (DKFZ) Heidelberg
Talk title: "Light ion beams for radiotherapy."
Program
Contributions to our program (talks, poster) are very welcome. Please submit your abstract during the registration process.
Possible contributions include (non-exclusively):
- biomedical application of nano-particles in radiation therapy,
- proton therapy,
- nanoparticles in neuro-oncology,
- neurosurgery and neuropathology,
- combined proton-nanoparticle therapy,
- cancer therapy.
Organizational Remarks
Date
January 26, 2023, 9 a.m. - 5 p.m.
Venue
online (MeetAnyway is expected to be used)
Conference Language
The official conference language is English.
Registration Fees
Participation in the NanoPorT workshop is free of charge.
Registration
For participation in the NanoPorT workshop please register online.
Downloads
- Call for abstracts (coming soon)
- Program
- Meetanyway guide (coming soon)
The SYNGOPRO Consortium
SYNGOPRO: Synergistic effects of gold nanoparticles and proton radiation in the treatment of childhood brain tumors
The SYNGOPRO consortium aims to apply synergistic effects of gold nanoparticles and proton radiation in the treatment of childhood brain tumors. This will be preclinically optimized until clinical validation is developed. Successful establishment of this combinatorial therapeutic approach (state-of-the-art proton therapy + gold nanoparticles) may contribute to a significant increase in the effectiveness of proton therapy. Consequently, shorter irradiation times will result, which will allow a larger number of children with cancer to have access to this life-saving therapy.
This project was funded by the European Regional Development Fund (ERDF)/ Dieses Vorhaben wurde aus Mitteln des Europäischen Fonds für regionale Entwicklung (EFRE) gefördert.
